Your browser does not support SVG.
  • HOME
  • PIPELINE
  • LEADERSHIP
  • DISEASES
    Acne vulgarisAtopic dermatitisHyperhidrosisPsoriasisVitiligo
  • NEWS
  • CAREERS
  • CONTACT

News

News

January 2, 2019

Dermavant Sciences Announces Appointment of Dr. Philip ...

Read More

December 6, 2018

Dermavant Sciences to Present New Data on Cerdulatinib ...

Read More

November 15, 2018

Dermavant Appoints Todd Zavodnick as Chief Executive Of ...

Read More

Recent Posts

  • Dermavant Sciences Announces Appointment of Dr. Philip M. Brown as Chief Medical Officer

  • Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit

  • Dermavant Appoints Todd Zavodnick as Chief Executive Officer

  • Dermavant Sciences to Present Tapinarof Phase 2B Data on Patient-Reported Outcomes for Psoriasis and Atopic Dermatitis at the Fall Clinical Dermatology Conference

  • Dermavant Announces Changes to Leadership and Board of Directors

Archives

  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • April 2018
  • September 2017
  • July 2017
  • December 2016
  • November 2015

Categories

  • Dermavant Sciences
  • News
  • RVT-201
  • RVT-501
  • RVT-502
  • RVT-504
  • Tapinarof
  • Home
  • Pipeline
  • Leadership
  • Diseases
    Acne vulgarisAtopic dermatitisHyperhidrosisPsoriasisVitiligo
  • News
  • Careers
  • Contact

Copyright © 2018 Dermavant Sciences, Inc. All rights reserved.
Privacy Policy    |   Terms of Use